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ABSTRACT
Saiboku-to (TJ-96), a traditional Kampo herbal forma-
tion, has been used in the treatment of bronchial
asthma in Japan as an anti-allergy herbal medicine.
We investigated the effect of TJ-96 on leukotriene (LT)C4
release from eosinophils and basophils isolated from
healthy volunteers. Pre-incubation of eosinophils with
TJ-96 inhibited ionophore- or formyl-methionyl-leucyl-
phenylalanine (FMLP)-induced LTC4 generation by
eosinophils in a dose-dependent fashion. The TJ-96
was more potent in the release by ionophore (IC50 = 60
mg/mL) than the release induced by FMLP (IC50 =
300 mg/mL). Maximal inhibition was observed when
eosinophils were pretreated with TJ-96 for 5 min.
Although TJ-96 at high concentrations inhibited IgE-
mediated histamine release from human basophils,
inhibition of IgE-mediated LTC4 release was not statis-
tically significant. The potent inhibitory activity was
found in the extract of Glycyrrhiza root, one of the
herbal components of TJ-96, but the inhibitory effects
were not due to either glycyrrhizin or liquiritin, the main
elements of the Glycyrrhiza root. These results raise the
possibility that the clinical efficacy of TJ-96 is derived, at
least in part, from its potent inhibitory effect on LTC4
release from eosinophils.
Key words: basophil, bronchial asthma, eosinophil,
Glycyrrhiza root, LTC4, Saiboku-to.
INTRODUCTION
Accumulation of eosinophils and basophils at the sites
of inflammation is a characteristic feature of allergic dis-
eases. Both eosinophils and basophils are recognized as
active participants in mediating allergic inflammation by
virtue of their capacity to generate and release a wide
array of preformed as well as newly generated chemical
mediators.1 Leukotriene (LT)C4, one of the newly generated
mediators, is a product of the 5-lipoxygenase pathway of
the arachidonate metabolism. The pivotal roles of LTC4 in
the pathogenesis of allergic inflammation have been well
established; LTC4 causes rapid and prolonged constriction
of smooth muscle as well as alterations in the vascular
tone and permeability.
Saiboku-to (TJ-96, Formula magnoliae et Bupleuri in
Latin), a traditional oriental herbal medicine, has been
used with some success in the treatment of patients with
bronchial asthma in Japan. Daily doses of TJ-96 consist
of 10 herbs (Table 1), and the clinical efficacy of TJ-96 in
patients with steroid-dependent bronchial asthma was
proven by a multicenter randomized and controlled clini-
cal trial.2 Although several in vitro as well as in vivo studies
have been performed to investigate the mechanisms of
TJ-96’s efficacy on asthma,3–7 the direct modulatory effect
of TJ-96 on the secretion of 5-lipoxygenase products in
human eosinophils and basophils has remained obscure.
Given the potential importance of pro-inflammatory
mediators in the pathogenesis of allergic inflammation
together with the therapeutic efficacy of TJ-96 in allergic
disorders, we decided to conduct an analysis of the
modulatory effect of TJ-96 on the secretion of LTC4 from
human eosinophils and basophils. Our results show that
TJ-96 exerts a potent inhibitory effect on LTC4 release
from eosinophils.
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MATERIALS AND METHODS
Reagents
Goat anti-human IgE antibody (concentration: 36.04 mg/
mL), Percoll, ionophore A23187 and formyl-methionyl-
leucyl-phenylalanine (FMLP) were purchased as described
previously.8 The TJ-96 and dried decoctem of medical herbs
were provided by Tsumura Co. (Tokyo, Japan). Glycyrrhizin
and liquiritin were purchased from Wako (Osaka, Japan).
Buffer
Pipes A buffer contained 25 mmol Pipes, 119 mmol NaCl,
5 mmol KCl, and 0.03% human serum albumin (pH 7.4).
For mediator release reactions, Pipes A containing 2 mmol
Ca2+ and 0.5 mmol Mg2+ (Pipes ACM) was used.
Cell preparation
Venous blood was obtained from healthy volunteers with
no history of atopic diseases such as bronchial asthma,
atopic dermatitis or chronic urticaria. All volunteers gave
informed consent. Because we intended to determine
the pharmacological efficacy of TJ-96, we did not select
donors according to Kampo diagnosis.
Eosinophils were isolated by Percoll gradient centrifuga-
tion as previously described.9 In some experiments,
eosinophils were further purified by negative selection
using anti-CD16 bound micromagnetic beads (Miltenyi
BioTech, Bergisch-Gladbach, Germany) and a magnetic-
activated cell sorter column (Miltenyi BioTech) as
described previously.9 Eosinophils were counted in
a hemocytometer (Tatai; Towa Kagaku, Tokyo, Japan) after
staining with Randolph’s stain. The purity of eosinophils
after Percoll gradient centrifugation was approximately
70%, and the viability was consistently greater than 95%.
For basophil mediator release, leukocytes were pre-
pared by dextran sedimentation as previously described.10
Mediator release
Histamine and LTC4 release were performed as previously
described.11 In brief, leukocytes were incubated with a test
reagent or control buffer for indicated time periods at
37°C. Mediator release reactions were evoked by the
addition of secretagogues and incubation was carried out
for an additional 45 min at 37°C. The tubes were then
centrifuged, and the supernatants were stored until assay.
Histamine was measured using an automated fluoro-
metric technique. The released LTC4 was quantitated
using an ELISA kit (LTC4/D4/E4 enzyme immunoassay
system, Amersham, Buckinghamshire, UK). Each experi-
ment was performed at least in duplicate.
RESULTS
Effect of TJ-96 on LTC4 release from eosinophils
The effect of TJ-96 on the release of LTC4 from eosinophils
was determined by incubating eosinophils with increasing
concentrations of TJ-96 for 15 min before stimulating
with ionophore A23187 or FMLP plus cytochalasin B (CB),
and then assaying released LTC4 in the supernatants by
enzyme immunoassay. As shown in Fig. 1, TJ-96 inhibited
LTC4 release initiated by both ionophore and FMLP in a
concentration-dependent fashion. The maximal inhibition
of TJ-96 was greater in ionophore-induced release than in
FMLP-induced release. Although the slope and the shape
of the concentration-response curve of TJ-96 were similar
with each of the stimuli, TJ-96 was more potent in inhibit-
ing the release induced by ionophore (IC50 = 60 m g/mL)
than the release induced by FMLP (IC50 = 300 m g/mL).
The viability of eosinophils treated with TJ-96 (1 mg/mL)
for 1 h was not significantly different compared with the
medium control as determined by trypan blue dye exclu-
sion (data not shown). In addition, the inhibition of LTC4
release caused by TJ-96 was a rapid process; maximal
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Table 1. Components of TJ-96
English name Japanese name Latin name Weight (g)
Bupleurum root saiko Bupleuri Radix 7.0
Pinellia tuber hange Pinelliae Tuber 5.0
Hoelen bukuryou Hoelen 5.0
Scutellaria root ogon Scutellariae Radix 3.0
Magnolia bark koboku Magnoliae Cortex 3.0
Jujube fruit taiso Zyzyphi Fructus 3.0
Ginseng root ninjin Ginseng Radix 3.0
Glycyrrhiza root kanzo Glycyrrhizae Radix 2.0
Perilla herb soyo Perillae Herba 2.0
Ginger rhizome shokyo Zingiberis Rhizoma 1.0
inhibition was observed when eosinophils were pretreated
with TJ-96 for 5 min (data not shown).
To the extent that the cellular preparations in the
aforementioned experiments contained contaminating
neutrophils (» 30%), we purified the eosinophils by
negative selection and tested the inhibitory effect of
TJ-96 on these highly purified eosinophils. The TJ-96
inhibited FMLP-induced LTC4 release from purified
eosinophil preparations (data not shown), indicating
that the inhibitory action on eosinophil’s LTC4 secretion
is not mediated indirectly such as by products derived
from contaminating neutrophils, but rather through
direct interaction of TJ-96 with eosinophils.
Effect of TJ-96 on mediator release
from basophils
In the next series of experiments we studied the effect of
TJ-96 on mediator release from basophils. The TJ-96 at
high concentrations inhibited IgE-mediated histamine
release from human basophils (Fig. 2a), but no statisti-
cally significant inhibition of IgE-mediated LTC4 release
was observed (Fig. 2b). In addition, TJ-96 was less potent
in inhibiting basophil histamine release compared with
eosinophil LTC4 secretion.
Effect of Glycyrrhiza root, Bupleurum root
and Scutellaria root on LTC4 release
from eosinophils
Saiboku-to is a herbal compound mixture of 10 common
herbal extracts. The pharmacological effects of TJ-96
are considered to be derived from three major herbs:
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Fig. 1 Dose-dependent inhibition of eosinophil LTC4 release
by TJ-96. Eosinophils were pre-incubated with serially diluted
TJ-96 for 15 min and then stimulated with ionophore A23187
(d, 0.1 m g/mL) or FMLP (s, 10–6 mol) plus CB (5 mg/mL).
After 45 min, the supernatants were obtained by centrifugation,
and LTC4 was measured by ELISA. Each value represents the
mean ± SEM.
Fig. 2 Effects of TJ-96 on basophil mediator release. (a) Leuko-
cytes were pre-incubated with serially diluted TJ-96 for 15 min
and then stimulated with anti-IgE (d), 12-o-tetradecanoyl-
phorbol-13-acetate (s), formyl-methionyl-leucycl-phenylalanine
(m), or ionophore A23187 (n) for 45 min. The supernatants
were obtained by centrifugation, and histamine was deter-
mined by an automated fluorometric technique. (b) Basophils
were partially purified by Percoll density centrifugation, and pre-
incubated with serially diluted TJ-96 for 15 min. LTC4 release
was initiated by anti-IgE. After 45 min, the supernatants were
obtained, and LTC4 was measured by ELISA. Each value repre-
sents the mean ± SEM.
Glycyrrhiza root (kanzo), Bupleurum root (saiko) and
Scutellaria root (ohgon). In our final series of experi-
ments, we evaluated the effects of these three compo-
nents on LTC4 release from eosinophils. As shown in
Fig. 3, Glycyrrhiza root at high concentrations showed a
concentration-dependent inhibition of LTC4 release initi-
ated by FMLP plus CB, whereas Bupleurum root and
Scutellaria root failed to exert a significant inhibitory
effect. Glycyrrhiza root contains large amounts of
glycyrrhizin (» 5 w/w%) and liquiritin (» 1 w/w%). Thus,
we examined the effects of these main elements of
Glycyrrhiza root on FMLP-induced LTC4 release from
eosinophils. However, high concentrations of glycyrrhizin,
for example 100 mg/mL, showed only marginal inhibi-
tion, and liquiritin (100 mg/mL) exerted no significant
inhibitory effect (data not shown). These results indicate
that the inhibitory effect of Glycyrrhiza root was due to
elements other than glycyrrhizin and liquiritin.
DISCUSSION
The clinical effectiveness of Kampo herbal medicines in
the treatment of some pathologic conditions has been
established by extensive experience in Japan. For over
1500 years, Hange-koboku-to and Sho-saiko-to have
been used to treat patients with a feeling of laryngeal
obstruction and common respiratory disorders, respec-
tively. Saiboku-to (TJ-96), a combined remedy of Hange-
koboku-to and Sho-saiko-to, was introduced in Japan
50 years ago as a remedy for wheezing, and it has recently
been applied in the treatment of bronchial asthma. By
acute and chronic toxicity tests in rats, the toxic dose levels
of TJ-96 were determined to be above 2000 mg/kg/day,
indicating low toxicity of the compound.
To date, there have been several studies designed to
evaluate the mechanisms by which TJ-96 achieves its
effects. It has been shown that TJ-96 modifies allergic
events through inhibition of Type I reactions in vivo,3,12
and through preventing the down-regulation of gluco-
corticoid and b -adrenergic receptors.4 Ex vivo studies
reveal that TJ-96 stimulates Na absorption by airway
epithelial cells, probably through nitric oxide generation.7
However, there have been no prior investigations of the
effects of TJ-96 on mediator release from human eosino-
phils and basophils.
In this study we provided several lines of evidence that
TJ-96 modulates the secretion of 5-lipoxygenase products
in eosinophils. We found that short-term pretreatment
with TJ-96 resulted in marked attenuation of eosinophil
LTC4 release initiated by both ionophore and FMLP in a
concentration-dependent fashion. Our next endeavor was
focused on identifying the active herbs and components in
TJ-96. Because Glycyrrhiza root,13 Bupleurum root and
Scutellaria root,14,15 among the 10 herbs contained in
TJ-96, were observed to show anti-allergic actions, we
tested the individual inhibitory effects of these herbs. Potent
inhibitory activity was shown by Glycyrrhiza root, whereas
inhibitory effect was not shown by its principal known
components, glycyrrhizin and liquiritin. Licochalcones,
isolated from Glycyrrhiza root, has been shown to exert an
inhibitory effect on ionophore-induced LTB4 and LTC4
formation in human neutrophils.13 We observed that
TJ-96 failed to inhibit IgE-mediated generation of LTC4
by basophils, although high concentrations of TJ-96
inhibited degranulation of these cells, indicating that the
effect of TJ-96 on eicosanoid release may be cell- and/or
stimulus-specific. Further study to identify the active mole-
cule(s) in Glycyrrhiza root may help us to answer these
issues.
It can be seen that TJ-96 exerted a potent inhibitory effect
on the secretion of eicosanoids by human peripheral blood
eosinophils stimulated with FMLP or ionophore. Our data
suggest that the clinical efficacy of TJ-96 in the treatment of
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Fig. 3 Effect of Glycyrrhiza root, (kanzo), Bupleurum root
(saiko) and Scutellaria root (ohgon) on formyl-methionyl-
leucycl-phenylalanine-induced LTC4 release. Eosinophils were
pre incubated with serially diluted extracts of Glycyrrhiza root
(d), Bupleurum root (s) or Scutellaria root (h) for 15 min.
LTC4 release was indued by addition of formyl-methionyl-
leucycl-phenylalanine. After 45 min, the supernatants were
obtained, and LTC4 was measured by ELISA. Each value repre-
sents the mean ± SEM.
bronchial asthma may be due in part to the inhibition of
eosinophil activation by this compound. The inhibitory
activity was found in the extract of Glycyrrhiza root. Because
the concentration of Glycyrrhiza root to inhibit LTC4 release
was rather high, further fractionation of Glycyrrhiza root will
be helpful to identify the active molecule(s).
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